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Abstract 
Central fatigue out of prolonged monotonous task and sleep deprivation in drivers accounts for 
majority of road-traffic accidents. This necessitates a precise staging of drivers’ fatigue in real 
time. The intent of this current study is to evaluate the overall fatigue in drivers by observing the 
variation of a series of biochemical and subjective parameters during simulated driving condition 
comprising monotonous task and sleep deprivation. Briefly, 12 well trained healthy drivers were 
subjected to simulated driving environment for a period of 16 hours with one night sleep 
deprivation. During the whole course of experiment, blood samples were collected at an interval 
of 5 hours and were analyzed for various biochemical parameters including random blood sugar, 
blood urea, serum creatinine, triglyceride, cholesterol and total protein content. In addition, the 
extent of fatigue was quantified by some subjective assessment such as SF36v2 Health Survey 
Scoring, Beck Depression Inventory and Oswestry Disability Questionnaire. All these 
parameters (both biochemical and subjective) gradually increased with the progress of fatigue. 
The subjective assessments concluded a substantial decline in health (both physical and mental) 
and a significant increase in depression level with the progression of fatigue. It was concluded 
that a combined result of biochemical parameters and subjective assessment can be utilized in 
clinical staging of fatigue. 
Key Words: central fatigue, sleep deprivation, creatinine, triglyceride, depression. 
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Introduction 
Fatigue from physiology point of view can be defined as the decreased capability or complete 
inability of an organism, an organ, or a part to function normally because of excessive 
stimulation or prolonged exertion [1]. Fatigue has a very complex origin, having a combined 
influence of events occurring in both periphery and central nervous system [4]. Accordingly 
fatigue has been divided in two components namely Physical fatigue or peripheral fatigue (PF) 
which occurs due to muscular dysfunction and central fatigue (CF) which occurs due to specific 
alterations in the central nervous system. The physical fatigue is a normal result of 
overstimulation, active recreation, and physical exertion etc., where as the central fatigue 
originates due to stress, workloads, depression, boredom, sleep deprivation etc. Even if both the 
terms seem to be dissimilar, it is quite difficult to differentiate both.  The central fatigue starts at 
molecular level much prior to the symptoms appears. The study published in many journals says 
CF appears due to certain neurotransmitters among which Serotonin or 5-HT (5-
hydroxytryptamine) is the most studied one. There are many literatures that suggest hypothesis 
for the genesis of CF among which Central Fatigue hypothesis proposed by E. Blomstrand is one 
of the most accepted versions [15]. This hypothesis is supported by many researchers in the later 
period. According her, during prolong exercise; there is an uptake of almost all amino acids 
along with branched chain amino acid (BCAA) by the muscle. This results in a decreased level 
of BCAA in plasma. Due to the decreased glycogen level, to fulfill the energy requirements, free 
fatty acid is released by adipose tissue. Since free fatty acid has more affinity for albumin, it 
replaces some of the tryptophan molecules bound to albumin (Curzon et al., 1973) [16] resulting 
an increase in plasma free tryptophan level. This results in an increased plasma free 
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tryptophan/BCAA level which in turn increased the amount of tryptophan crossing the blood 
brain barrier. Tryptophan is a precursor molecule for the synthesis of serotonin, hence plays an 
important role by synthesis, concentration and release of 5-HT in the brain (Newsholme, 1986) 
[17]. This brain 5-HT is involved in control of sleepiness, arousal and mood, hence linked with 
the central fatigue during sustained exercise.  
After prolong CF, distortion in the peripheral metabolism starts, due to improper commands 
from brain, which initiates peripheral fatigue (PF). Again PF releases certain waste products that 
in turn add to the CF. In this manner both the fatigue components act in a vicious manner. So 
after certain period of induced CF; peripheral blood parameter can suitably represent the stages 
of CF. CF can have many diverse origins out of which sleep deprivation is  one of the major 
cause which can impair brain activities as much as alcohol can. Sleep is a fundamental 
restorative process for the nervous system. Severe impairments of the operator’s ability to 
perceive, recognize, and respond to emergencies and unanticipated events can occur with the 
disruption of this homeostatic drive [2]. This has increased a risk of mishaps in military, aviation 
as well as road transportation sector.  Hence establishing a comparative study of sleep 
deprivation on human performance is essential in order to develop mitigation strategies to 
counter fatigue.  
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Literature Survey 
Driver’s fatigue is one of the major problems in transport systems. According to a study done by 
Harvard Medical School, it was found that 28% of the adult drivers actually fallen asleep during 
driving whereas around 54% of the drivers had feeling of drowsiness on wheels. The National 
Highway Traffic Safety Administration reports 1.55% death rate and 40% injury annually due to 
drowsy driving. Report by Sleep Research Centre says 20% of the major serious road accidents 
are caused due driver’s fatigue i.e. falling asleep at the wheel in Great Britain [3]. A study in 
USA says 50% road accidents on two of America’s busiest roads were fatigue related [4]. In 
support to this another study says 30-40% of road accidents involving heavy vehicles are caused 
by driver sleepiness [5]. An Australian road safety organization estimates that 6% of road 
mishaps, 15% fatal accidents and 30% fatal crashes were due to driver’s fatigue. World Health 
organization report in 2009 says more people die in India due to road accidents than anywhere 
else in the world. 
Studies in various countries say young male drivers (age 25 ± 5) are more prone to sleep related 
crash due to their tight schedule and tendency to drive high mileage on freeways. While 
considering the time of Day the results are even more interesting. It was found that sleep related 
accidents were peak in the early hours (between 02:00 Hrs – 06:00 Hrs). According to study 
done by Horne, it was found that the drivers were 50 times more prone to fall asleep at wheel at 
02:00 Hrs than at 10:00 Hrs [6]. It was also found that in case of long journey on monotonous 
roads the probability of falling asleep is more. Recent research in New Zealand suggests that 
staying for 17-19 hours awake results the equivalent level of impairment in brain function as 
drinking of around 50 ml of alcohol induces [7]. 
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Monotonous exercise with sleep deprivation, particularly driving over prolonged period can 
induce fatigue which is developed with gradual increase in cerebral metabolism [9-11]. Various 
blood biochemical parameters particularly the neurotransmitters and their metabolic products, 
blood glucose, urea, creatinine, triglyceride, total protein content in blood represents either the 
inducer or the outcome of the events leading to fatigue. These parameters can reliably reflect the 
gradual genesis and progression of fatigue.  
Apart from the blood biochemical parameters, the subjective assessment of the individuals can 
also reflect the level of fatigue. The Beck depression inventory reflects the gradual increase in 
the depression and languorous along with the progression of fatigue. Apart from this SF36v2 
health survey and Oswestry disability questionnaire give the variation of mental as well as 
physical health parameters along with fatigue genesis and its subsequent staging. 
In this work an attempt has been made to simultaneously measure the various blood biochemical 
parameters and subjective measurement. In each type of measurement multiple factors have been 
analyzed and their relation with fatigue progression has been evaluated. 
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This chapter describes the materials, methodology and the protocols followed for the estimation 
of the biochemical parameters, the set up of the simulator for the fatigue study. 
3.1 Materials 
All the assay kits used for the analysis of the various biochemical parameters are certified for 
IVD (in vitro diagnosis). The Glucose Kit, Urea Kit, Creatinine Kit, triglyceride Kit, Cholesterol 
Kit were procured from CREST BIOSYSTEMS; total protein assay kit was procured from 
AutoZyme, ACCUREX biomedical Pvt. Ltd.; and the CK-MB kit was procured from 
CHEMELEX, S.A. The blood collection tubes and disposable syringe were obtained from BD 
BIOSCIENCES (India). For the colorimetric analysis of the blood sample, a semi automated 
biochemical analyzer (EVOLUTION 3000) was used. 
3.2 Simulator Setup 
The simulator consist of a PC (specification), truck simulator software (EURO TRUCK), a 
software compatible steering wheel (900º rotation) with a vibration leg pad and hydraulic brake 
system (Driving Force GT, Logitech, India), an LCD projector, a HD Sound system(INSPIRE M 
4500™, CREATIVE) and a screen. The simulator module along with the audio visual unit was 
installed in the PC. The projector and the screen were placed in such ways that, the driver can get 
a clear visibility. The whole setup was arranged keeping drivers ergonomics in point of view. 
3.3 Subjects 
Twelve healthy male human individuals of different age group (39.2±12.3 SD) who were trained 
with heavy vehicle driving were hired from the Regional State transport Division located at 
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Sector-2, Rourkela, Odisha. Since drivers fatigue is a result of several factors such as irregular 
driving schedule, long time driving, sleep deprivation, mental and psychological conditions etc, 
and the similar conditions were simulated in the laboratory environment by articulating 
volunteers to undergo monotonous exercise with sleep deprivation. Prior to the experiments, the 
subjects were undergone strict clinical examination by registered medical practitioner and were 
declared healthy. An informed consent in written form was obtained from each subject. Their 
blood samples were collected in periodic intervals for the estimation of various blood 
biochemical parameters to get the genesis and progressive stages of fatigue development.  
3.4 Experimental Design 
The experiment was conducted under laboratory stimulatory conditions with two subjects in a 
single session. The entire experiment was subdivided into multiple stages (for every individual, 
starting time of different stages were Day-1: Stage1- 18:00Hrs, stage2-00:00Hrs; Day-2: Stage3-
05:00 Hrs, stage4-10:00 Hrs), and in each stage the individual was asked to perform virtual 
driving on simulator to generate mental as well as visual fatigue. Prior to the experiment the 
individuals were asked to perform their normal day to day activity except certain activities like 
sleeping in the afternoon, any consumption of alcohol, caffeine, and tobacco etc. Just before the 
start of the experiment (18:00 Hrs), each participant was subjected to a series of questionnaire for 
their subjective assessment before induction of any fatigue. In addition, the first blood sample 
was collected (that serves as the control) followed by a predesigned snacks. The subjects were 
kept awake during the whole session of the driving simulation. The successive blood samples 
were collected at 00:00Hrs, 05:00Hrs, and 10:00 Hrs to observe the effect of fatigue on 
biochemical parameters. At the same time the subjective assessment was also repeated at the 
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same time points of blood collection. They were also made to undergo monotonous exercise at 
regular intervals thus with sleep deprivation and monotonous exercise an artificial fatigue 
condition was simulated in vitro.  
Time points  
 
18:00 Hours 
DAY-1  
21:00-22:00 Hours 
DAY-1  
00:00 Hours 
DAY-2  
05:00 Hours 
DAY-2  
10:00 Hours 
DAY-2  
Analysis:  
1. Biochemical parameters  
2. Subjective assessment 
 
Dinner Break Analysis:  
1. Biochemical parameters  
2. Subjective assessment 
 
Subject : 12 Healthy Human beings 
 
3.5 Blood Sample Collection 
The blood sampling was done four times throughout the experiment from all the individuals. 
Briefly a tourniquet was wrapped around either arm (left or right arm altering at each time point) 
of the individual and was asked to flex the elbow as well as the fingers. From the anterior region 
of the elbow, 5ml of blood was collected by puncturing the brachial vein through 5ml disposable 
syringe fitted with 22G needles (BD Biosciences, India) after sterilizing it with a cotton swab 
soaked with 70% alcohol. 2ml of the blood was collected in a tube containing clot inhibitor (Na-
EDTA) to obtain whole blood, and the remaining 3ml was collected in tubes containing clot 
activator(coated with Silicone gel,AkuSet™,Eastern Medikit Limited) to obtain serum, for the 
biochemical and the immunological assays. The samples were vortexed 8 times for proper 
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mixing followed by preservation in refrigerator at 2-8ºC.Later the samples were analyzed for 
various blood biomarkers. 
3.6 Measurement of Blood Biomarkers 
The blood sample was centrifuged at 3200 rpm for 12minutes and then the plasma was collected. 
The estimation was done by the help of semi-automated Biochemical Analyzer (Evolution 3000) 
using marketed kits. (Crest Diagnostics). 
3.6.1 Glucose assay 
3.6.1.1 Procedure 
Wavelength/filter     : 505nm/green  
Temperature             : 37ºC 
 
3.6.1.2 Sample preparation 
Three clean and dry test tubes were taken and marked Blank (B), Standard(S), and Test (T). 
Then the sample and the reagents were added in the following sequence. 
Addition sequence B (ml) S(ml) T(ml) 
Glucose Reagent (L1) 1.0 1.0 1.0 
Distilled Water 0.01 - - 
Glucose Standard(S) - 0.01 - 
Sample - - 0.01 
All the mixtures were mixed well and incubated at 37ºC for 10minutes. Then the absorbance was 
measured. 
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3.6.2 Urea Assay 
3.6.2.1 Procedure 
Wavelength/Filter    : 570 nm/ yellow  
Temperature             : 37ºC 
3.6.2.2 Sample Preparation 
Three clean and dry test tubes were taken and marked Blank (B), Standard(S), and Test (T). 
Then the sample and the reagents were added in the following sequence. 
Addition Sequence B(ml) S(ml) T(ml) 
Buffer Reagent 1.0 1.0 1.0 
Enzyme Reagent 0.1 0.1 0.1 
Distilled Water 0.01 - - 
Urea standard - 0.01 - 
Sample - - 0.01 
The above preparation was mixed well and incubated for 5min. at 37ºC 
Chromogen reagent(L3) 0.2 0.2 0.2 
 
Again the preparation was mixed well and was incubated for 5min. at 37ºC and then the 
absorbance was measured. 
3.6.3 Creatinine assay 
The blood sample with coagulant was taken and the serum was separated. This was centrifuged 
at 3200 rpm for 12minutes and then the serum was collected. The estimation was done by the 
help of semi-automated Biochemical Analyzer (Evolution 3000) using marketed kits. (Crest 
Diagnostics). 
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3.6.3.1 Procedure 
Wavelength/filter       : 520nm/green 
Temperature            : 30ºC/37ºC 
3.6.3.2 Sample Preparation 
Two clean and dry test tubes were taken and marked as Standard(S), and Test (T). 
Then the sample and the reagents were added in the following sequence. 
Addition sequence (S)/(T)     30ºC/37ºC (T) in ml  30ºC/37ºC 
Picric Acid Reagent 0.5 ml  0.5 ml 
Buffer Reagent 0.5 ml 0.5ml 
Creatinine Standard (S) 0.1 ml 0.1 ml 
The preparation was mixed well and the first absorbance was taken exactly after 30secs and the 
second one was taken exactly after 60 sec. since it’s a semi-automated analyzer the whole thing 
was programmed. 
3.6.4 Triglycerides Assay 
3.6.4.1 Procedure 
Wavelength/Filter: 505nm/Green 
Temperature: 37ºC 
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3.6.4.2 Sample preparation 
Three clean and dry test tubes were taken and marked Blank (B), Standard(S), and Test (T). 
Then the sample and the reagents were added in the following sequence. 
Addition sequence B (ml) S(ml) T(ml) 
Working Reagent 1.0 1.0 1.0 
Distilled Water 0.01 - - 
Triglycerides Standard(S) - 0.01 - 
Sample - - 0.01 
 The above preparations were mixed well and incubated at 37ºC for 5 min. Then the absorbance 
was measured. 
 
3.6.5 Cholesterol Assay 
3.6.5.1 Procedure 
Wavelength/Filter: 505nm/Green 
Temperature: 37ºC 
3.6.5.2 Reagent Preparation 
The two reagents L1 and L2 were mixed in a 4:1 ratio. This works as a working reagent.  
3.6.5.3 Sample preparation 
Three clean and dry test tubes were taken and marked Blank (B), Standard(S), and Test (T). 
Then the sample and the reagents were added in the following sequence. 
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Addition sequence B (ml) S(ml) T(ml) 
Working Reagent 1.0 1.0 1.0 
Distilled Water 0.01 - - 
Cholesterol Standard(S) - 0.01 - 
Sample - - 0.01 
 The above preparations were mixed well and incubated at 37ºC for 5 min. Then the absorbance 
was measured. 
 
3.6.6 Total Protein Assay 
3.6.6.1 Procedure 
Wavelength: 546nm (530-570 nm) 
Temperature: 25-30ºC 
3.6.6.2 Sample preparation  
Three clean and dry test tubes were taken and marked Blank (B), Standard(S), and Test (T). 
Then the sample and the reagents were added in the following sequence. 
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Addition sequence B (ml) S(ml) T(ml) 
Working solution 1.0 1.0 1.0 
protein Standard      -       0.01 - 
Sample      -     -   0.01 
 The above preparations were mixed well and incubated at 37ºC for 5 min. Then the absorbance 
was measured.  
3.7 Subjective assessment 
The subjective assessment for fatigue is based on a set of questionnaires which were asked to 
each subject at the end of each step. For this assessment three standard protocols were followed 
namely SF36 V2 health survey that scores the individual general health status and related quality 
of mental and physical status during the task/disease/intervention; Beck Depression Inventory 
(BDI-II), which consists 21 multiple choice self reportable questions, have a basic motto to 
estimate the severity of depression and detachment from the current task in the subject; Oswestry 
Disability Questionnaire which is basically used to determine the extent of pain and disability out 
of an intervention. All these assessment instruments were slightly modified as per the 
requirement of the current study and the details are supplied in appendix-I. 
The questions were asked through an interactive session and the scoring was done on the 
combined view of the subject’s self assessment and the observation of one of the member of the 
research team. 
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3.7.1 SF36v2 questionnaire 
SF36v2
®
 Health Survey is a set of questionnaires designed by Quality Metric Inc. which gives 
valid information about functional Health of an individual. This generic health survey can be 
used across age groups, diseases, and is appropriate for a wide variety of applications worldwide.  
This SF36v2
® 
Health Survey asks 36 questions to measure the functional health and the well-
being from the patient’s point of view [12]. The survey is meaningful to clinicians, researchers, 
and administrators across the health care spectrum [12]. This has various applications which 
include assessing treatment effectiveness, measuring health improvement or decline, comparing 
health factors across population etc. The detail information has been provided in Appendix-I.  
3.7.2 Beck Depression Inventory 
Beck Depression Inventory invented by Beck, is a set of questionnaire used for the assessment of 
depression level in patients, professionals etc. The recent version BDI-II is a generic instrument 
that can be used across age groups above thirteen, and is composed of questionnaires that relate 
to depression level (hopelessness, irritability etc.) , cognitions (guilty feeling, feeling of being 
punished etc.) as well as physical symptoms [13]. The details of the questionnaire section is 
provided in appendix-I. 
3.7.3 Oswestry Disability Questionnaire   
This is one of the extremely important tools that researchers and clinicians use to measure 
patient’s permanent disability. This ten questionnaire section gives us the information of how the 
body pain affects the ability to manage the day to day life. 
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The result section is divided in two parts. 
1. Blood Biochemical measures 
2. Subjective assessment Results 
4.1 Blood biochemical measures 
4.1.1 Glucose level in whole Blood 
The average value of the blood glucose level (RBS) in the subjects gradually increased in 
accordance with level of fatigue and the duration of the sleep deprivation i.e. Stage1: 94.23 ± 
2.24, Stage2: 104.85 ± 2.07, Stage3: 125.15 ± 2.86, Stage4: 107.77 ± 1.63 (Figure-1) . However, 
RBS at 4
th
 time point (10:00 hrs) of the second day followed by one night of sleep deprivation 
decreased. This indicates RBS reached maximum at the peak of sleep debt. 
 
Figure-1: Average Random Blood sugar (RBS) level 
Earlier researchers have found profound alteration in the glucose metabolism during sleep 
deprivation. Studies say, during highest of the sleep debt, the subjects took 40 percent longer 
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duration to regulate their blood sugar level following an injection of glucose. The ability to secret 
insulin was decrease about 30 percent [14].  
4.1.2 Creatinine level in serum 
The creatinine level increased proportionately with the duration of sleep deprivation (Figure-2). 
The end point result shows an increased concentration of creatinine which above the normal 
cutoff signifying that kidney functions might be compromised. 
 
Figure-2: Creatinine level in Serum 
The increased creatinine concentration is a significant parameter of peripheral fatigue that 
involves muscle atrophy which in turn might have surcharged the kidneys. The increase in this 
peripheral indicator of fatigue can be explained by spread of persistent central fatigue to the 
periphery which in turn leads to the degradation of muscle protein. At the same time, various 
amino acids are also produced from protein catabolism along with tryptophan that crosses BBB 
to aggravate central fatigue, generating a vicious cycle [18-20].  
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4.1.3 Urea level in Blood 
The blood urea level also showed an increasing trend with the progression of fatigue as depicted 
in the figure-3.  
 
Figure-3: Urea Level in Blood 
 
The more logical way of expressing blood urea is the form of Blood Urea nitrogen (BUN). BUN 
(normal range=7-21 mg/dL) is the measure of amount of nitrogen in the blood present in the 
form of Urea and is a measurement of renal function. The trend in BUN, that was estimated from 
the blood urea level [BUN= Urea (mg/dL) / 2.14] showed obviously the same trend as that of 
blood urea (Figure-4).  
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Figure-4: Blood Urea Nitrogen Level 
 
A regular elevation in blood Urea level as well BUN in the course of experiment may suggest 
either increased protein catabolism to supply energy needs as observed and reported in 
conditions of sleep deprivation [21] or it may suggest the impaired renal function (since the 
subjects were healthy and had no systemic abnormalities verified by clinical examinations, 
obviously this is not the case). Moreover, an elevated BUN level in the scenery of relative 
normal creatinine concentration may reflect a physiological situation of a relative decrease of 
blood flow to the kidney without indicating any kidney dysfunction. Thus BUN to serum 
creatinine ratio acts as a clinically significant indicator of kidney function which has been shown 
in Figure-5. 
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Figure-5: BUN to Creatinine Ratio 
When the BUN to Creatinine ratio (BUN:creatinine) is higher (in close proximity to 20), the 
subject is suspected of having prerenal azotemia i.e. the intrinsic function of kidney is normal but 
nitrogenous waste are produced as a result of muscle degradation. Since in the current study the 
BUN/Creatinine ratio was gradually decreasing (but remained within the normal range) with the 
time, it indicates a depletion in body protein. 
4.1.4 Triglyceride and cholesterol level in blood: 
The blood cholesterol level did not show much variation (figure not shown) with fatigue 
development in drivers while triglyceride level (Stage1: 121.5 ± 8.5, Stage2: 143.25 ± 10.6, 
Stage3: 173.75 ± 14.2, Stage4: 166 ± 5.5) showed a gradual increase (figure-6) indicating 
continuous release of the later between the meals to compensate energy demand of monotonous 
exercise.  
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Figure-6: Triglyceride Level in Blood 
4.1.5 Total protein Content in blood: 
The total protein content did not vary much and remained in the normal range (6.3 to 8.4 gm %). 
As shown (figure-7) the protein content in blood decreases except the last point which increases 
a little.  
 
Figure-7: Total protein content in blood 
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4.2 Subjective assessment 
The subjective assessment study was done following three instruments namely  
i. SF-36 v2  health survey scoring 
ii. Beck Depression Inventory (BDI-II) 
iii. Oswestry Disability Questionnaire 
4.2.1 SF-36v2 Health Survey 
SF-36v2 health survey is one of the most reliable, practical surveys and provides valid 
information about the patient’s health condition. It has two components namely Physical 
Component Summary (PCS) and Mental Component Summary (MCS). Again these each part 
consists of some subdivisions. The PCS gives the summary of Physical Functioning (PF), Role 
Physical (RP), Bodily Pain (BP), and General Health (GH). Each of this section consists of few 
questionnaires. Again coming to MCS, it consists of Vitality (VT), Social Functioning (SF), Role 
Emotional (RE), and Mental Health (MH). The details of the questionnaires is provided in 
appendix-I. The average result summary is given below. 
4.2.1.1 Physical Component Summary (PCS) 
4.2.1.1.1 Physical Functioning (PF) 
Physical functioning account for multiple tasks completing capability that involves physical 
movement likely vigorous activities (running, lifting etc.), moderate activities (moving a table, 
bowling etc.), walking (small distance of hundred yards, medium distance and long distance), 
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lifting and carrying, climbing , bending , kneeling, self maintenance (bathing, dressing etc.). 
During the whole period of the experiment, the questionnaires were customized as per our 
requirement and the scoring was expressed as Mean ± SEM. The score varied from around 50 to 
a minimum of 25 (Stage1- 51.78±1.59; Stage2- 46.12±2.05, Stage3- 39.12±1.80, Stage4- 
25.22±1.16). The value 51.78±1.59 at the starting of the experiment signifies that the subject is 
able to do the mentioned tasks; whereas, with the gradual progression of the experiment the 
value decreases drastically signifying the increased disablement of the subject to perform the 
minimal possible task defined by the system.   
 
Figure-8: Physical Functioning (PF) 
4.2.1.1.2 Role Physical (RP) 
This parameter accounts for the ability of the subject to perform the defined task. Role physical 
enquires about the cut down in the amount of time that the subject spends on a particular activity, 
the accomplishment time, level of difficulty in performing the work (taking extra effort for a 
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specific job) etc. The scoring values vary (Stage1- 64.73 ± 0.82, Stage2- 52.80 ± 1.16, Stage3- 
38.82 ± 2.16, and Stage4- 32.87 ± 2.25) which are decreasing in a similar to that of Physical 
functioning. 
 
Figure-9: Role Physical (RP) 
4.2.1.1.3 Bodily Pain (BP)   
Bodily pain strictly accounts for the magnitude of the pain and the obstruction/ interference 
created by it in the general regular activities during the period of experiment. From the figure-10, 
the decreasing value of the scoring (Stage1: 50.8 ± 1.1, Stage2: 48.7 ± 1.4, Stage3: 38.5 ± 0.7, 
Stage4: 35.9 ± 1.1) clearly signifies the increasing extent of pain towards the completion of the 
experiment.   
28 | P a g e  
 
 
Figure-10: Bodily Pain (BP) 
4.2.1.1.4 General Health (GH) 
General health mainly concerns regarding the general feeling for the health condition at the 
moment (feeling of getting sick easily as compared others, expecting the health to get worse in 
the coming hours, realizing that you are as healthy as your surround people etc.). The scoring 
values for General Health are Stage1- 68.63 ± 1.24, Stage2- 54.90 ± 0.92, Stage3- 42.08 ± 1.80, 
and Stage4- 33.85 ± 1.53. The average general health scoring values shows a declining trend 
along with the progression of fatigue. 
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Figure-11: General Health (GH) 
On overall analysis the Physical Component Summary (PCS) comes out to be: 
All the parameters such as physical functioning (PF), Role-Physical (RP), Bodily Pain (BP), and 
General Health (GH) that account for the physical health condition at a time point can be 
summarized under the heading of Physical Component Summary (PCS). The PCS value 
gradually decreases (Stage1: 60.50 ± 2.1, Stage2: 52.23 ± 1.3, Stage3: 41.52 ± 0.6, Stage4: 33.70 
± 0.3) with the progression of fatigue with an inference that the physical health condition 
declines with fatigue combined with sleep deprivation.   
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Figure-12: Physical Component Summary (PCS) 
4.2.1.2 Mental Component Summary (MCS) 
4.2.1.2.1 Vitality (VT) 
Vitality is a factor that explains strength and liveliness. This factor is an unseen force that has 
contribution to both physical as well as mental health condition. The response to the 
questionnaires in this section reveals the subject’s feeling of full of life, any nervousness 
regarding completing the task, down/dumbness, calm and cheerful, a sense of ineffectiveness, 
getting exhausted etc. The average scoring was found to be Stage1: 74.1 ± 0.9, Stage2: 60.4 ± 
0.9, Stage3: 43.0 ± 0.8, Stage4: 31.5 ± 1.3. It was observed that this vital component was 
decreasing from 74.1 ± 0.9 (Stage1), at the starting of the experiment which reflects a quite good 
and healthy condition to 31.5 ± 1.3 (Stage4) which is near to the worst condition. This drastic 
change signifies a remarkable increase in anxiety and disquiet.  
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Figure-13: Vitality (VT) 
4.2.1.2.2 Social Functioning (SF) 
The social functioning (SF) scoring values were decreasing gradually (Stage1: 64.8 ± 0.7, 
Stage2: 48.7 ± 0.9, Stage3: 43.2 ± 0.9, Stage4: 31.8 ± 1.3) along with the increasing effect of 
fatigue as shown in figure. The term Social Functioning here refers to the extent of effect of 
physical health and emotional problems on social life of a being and their duration. From the 
decreasing value in the Social Functioning the conclusion can be drawn that the subject was 
losing his interest in social activities at the very point. This might be arising due to annoyance 
and desperation. 
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Figure-14: Social Functioning (SF) 
4.2.1.2.3 Role Emotional (RE) 
Role Emotional (RE) factor deals with the feelings of depression or anxiety and the effect of 
emotional problems on day-to-day life activity. The scoring value (Stage1: 62.5 ± 1.2, Stage2: 
48.8 ± 1.7, Stage3: 38.4 ± 0.7, Stage4: 20.5 ± 1.3) also decreases along with the progression of 
fatigue, which signifies the increasing level of distress and apprehension for social life.  
 
Figure-15: Role Emotion (RE) 
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4.2.1.2.4 Mental Health (MH) 
This factor explains the role and contribution of nervousness, downheartedness, extent of feeling 
peaceful and happiness on the generation of fatigue. Similar to the other factors, mental health 
(MH) also decreased (Stage1: 61.7 ± 0.9, Stage2: 50.5 ± 1.1, Stage3: 33.4 ± 1.0, Stage4: 23.0 ± 
1.6). This significance decrease in scoring value explains a decline in mental health condition.  
 
Figure-16: Mental Health (MH) 
On overall analysis the Mental Component Summary (MCS) comes out to be: 
Aggregating the components such as Vitality (VT), Social Functioning (SF), Role Emotion (RE), 
Mental Health (MH), an cumulative result comes which is termed as Mental Component 
Summary (MCS).  The average scoring values of MCS (Stage1: 67.4 ± 0.8, Stage2: 52.3 ± 1.1, 
Stage3: 42.0 ± 0.6, Stage4: 27.5 ± 1.4) shows a declining trend with the progression of fatigue.  
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Figure-16: Mental Component Summary (MCS) 
From over all analysis of SF36v2; the outcome signifies that there is a substantial decrease in 
both physical and emotional level as the progression in fatigue occurs.   
4.2.2 Beck Depression Inventory (BDI-II) 
The scoring is expressed as Mean ±SEM. The average scoring values were found to be (S1: 3.16 
± 0.84, S2: 9 ± 0.52, S3: 14 ± 0.26, S4: 16.8 ± 0.12). The result of all stages is shown in the 
figure-17. 
In Beck Depression Inventory, from psychodynamic prospective, the analysis is done on two 
factor approach to depression. According to Beck Inventory, Depression can have two 
components i.e. affective component which contains  eight items namely pessimism, feeling of 
past failure, guiltiness feeling, feeling of punishment, self-dislike, self-criticalness, 
worthlessness, suicidal thoughts; whereas the somatic component consists of agitation, loss of 
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pleasure, sadness, crying, loss of energy, loss of interest, indecisiveness, irritability, change in 
appetite, tiredness, concentration difficulties, change in sleep pattern and loss of interest[22][23]. 
In most of the subjects it was observed that the scoring was gradually increasing along with the 
progression of fatigue. It was found that in most of the subjects, the somatic depression was more 
dominant as compared to the affective depression during towards the completion of the whole 
task. As we can observe that the percentage change in the mood disturbance over first time point 
(control) is 184.8%, 158.2%, 88.6% in the successive three stages. The relative decrease in the 
last stage can be explained by the subject’s feeling of assurance that the task is getting over after 
a prolonged binding to a task. However, all the scoring values were coming under low level of 
depression (mild mood disturbance) and need not any kind of professional treatment.  
 
Figure-17: Beck Depression Inventory 
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4.2.3 Oswestry Disability Questionnaire 
 In order to know the extent of pain, Oswestry Disability Questionnaire is one of the best 
methods. This is considered as the golden rules for the evaluation of pain. The scoring was 
expressed as Mean± SEM. The average scoring was found to be (S1-2.50 ± 0.01 %, S2- 
5.20±0.01%, S3- 14.30±0.01%, S4- 24.70±0.02%). The increasing score indicates gradual 
increase in the pain out of fatigue. The scoring also discriminates the different stages of fatigue. 
 
  Figure-18: Oswestry Disability Questionnaire 
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Chapter-5 
 
 
             Conclusion 
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        Drivers fatigue under sleep deprivation consist of multiple factors likely emotional 
distortion i.e., distraction from the task, despair/depression, exhaustion, lethargy, languorous 
(feeling of lack of interest or energy), lassitude (lack of vitality or energy), somnolence (a very 
sleepy state) etc. If fatigue (both motor and cognitive) is combined with sleep deprivation for a 
prolonged period as occurs in long distance driving, it can lead to psychosomatic pain which in 
turn can generate substantial depressive feeling in the subjects. In the current study, the various 
factors (both biochemical and subjective) advocate that with the progression of fatigue multiple 
parameters alter following a similar trend. The increased creatinine level in blood and the 
gradual decrease in the BUN/Creatinine ratio signify depletion of muscle protein due to 
progression of central fatigue and its spread to the periphery for the development of physical 
fatigue. The gradual increase in Triglyceride concentration may be to compensate the energy 
demands during progression of fatigue, which goes in support of the above statement. Coming to 
the psychometric parameters, all are altering following a similar trend. PCS suggest a gradual 
decline in physical functioning and performance with progression of fatigue. The level of pain 
was found to be increasing as signified by PCS, which is again supported by the Oswestry 
Disability Questionnaire. This infers a substantial rate increase in both somatogenic as well as 
psychogenic pain with the progression of fatigue. The correlation of BDI and Role Emotion 
gives a value -0.97, which signifies with the decreasing value of Emotional component of MCS 
the BDI scoring increases proportionally ensuring a considerable increase in the level of 
depression with progression of fatigue. Since the BDI value is within the limit (< 17%: mild 
mood disturbance), the subject doesn’t require any professional treatment. The significant 
variation of these parameters (both biochemical and psychometric) suggest that they can be 
effectively utilized for clinical staging of fatigue. 
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Blood Glucose assay 
Principle: In the presence of enzyme Glucose oxidase, glucose is oxidized to Gluconic acid and 
hydrogen Peroxide. This hydrogen Peroxide further reacts with phenol and 4-aminoaantipyrine. 
This occurs due to catalytic action of peroxidase forming a red colored quinonemine dye 
complex. The intensity of the color formed in the solution is directly proportional to the amount 
of glucose present in the sample. 
      Glucose Oxidase 
     Glucose + O2 + H2O                                                  Gluconate + H2O2 
 
           Peroxidase 
H2O2 + 4aminoantipyrine + Phenol                                     Red Quenoneimine dye + H2O 
 
 
 Urea Assay 
Principle: Urea is hydrolyzed to ammonia and CO2 in the presence of enzyme Urease. The 
ammonia formed then reacts with phenolic chromogen and hypochlorite to from green colored 
complex. The intensity of the color formed is directly proportional to the amount of Urea present 
in the sample.  
     Urease 
                  Urea + H2O                                  ammonia + CO2    
 
Ammonia + Phenolic Chromogen + Hypochlorite        Green color complex 
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Creatinine assay 
Principle: In the alkaline medium Picric acid react with creatinine to form a orange color 
complex with the alkaline picrate. Intensity of the color formed is directly proportional to the 
amount of the creatinine present in the sample. 
 
Creatinine + Aklaline picrate                         Orange colored Complex 
 
Triglycerides Assay 
Principle: Lipase enzyme hydrolyzes the triglycerides to glycerol and free fatty acids. The 
glycerol produced, in the presence of Glycerol kinase consumes one ATP to form Glycerol 3 
phosphate, which is further oxidized to Dihydroxyacetone phosphate producing H2O2. This H2O2 
in the presence of peroxidase, react with 4AAP and phenol to form a red color dye. 
   Lipoprotein Lipase 
     Triglycerides     Glycerol + Free fatty acids 
 
 
                  Glycerol Kinase 
     Glycerol + ATP      Glycerol 3 phosphate + ADP 
 
 
       Glycerol 3 Phosphate Oxidase 
  Glycerol 3 Phosphate + O2            dihydroxyacetone phosphate + H2O2 
 
 
          Peroxidase 
    H2O2 + 4AAP + phenol             Red Quinoneimine dye + H2O 
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Cholesterol Assay 
Principle: The cholesterol easters in the presence of Cholesterol easterase hydrolyzes to 
Cholesterol and Fatty acids. This Cholesterol is oxidized to Cholestenone in the presence of 
Oxidase enzyme producing H2O2. This H2O2 produced react with 4AAP and phenol forming a 
Red Quinoneimine dye. The amount of the Cholesterol present is directly proportional to the 
intensity of the color of the solution. 
 
            Cholesterol Easterase 
Cholesterol easters + H2O     Cholesterol + Fatty Acids 
 
 
             Cholesterol Oxidase 
               Cholesterol+ O2     Cholestenone + H2O2 
 
H2O2 + 4AAP + Phenol        Red Quinoneimine dye + H2O 
 
Total Protein Assay: 
Principle: Under alkaline pH condition, protein reacts with cupric ions producing a blue color 
complex. This colored complex absorbs light at 546nm. The amount of protein present is directly 
proportional to the intensity of color produced. 
 
     Cu
2+
  
Proteins       Blue Color Complex 
                   Alkaline pH 
 
 
 
